First Time Loading...

Mentice AB
F:MN2

Watchlist Manager
Mentice AB Logo
Mentice AB
F:MN2
Watchlist
Price: 16.235 EUR -0.02%
Updated: May 13, 2024

Wall Street
Price Targets

MN2 Price Targets Summary
Mentice AB

Wall Street analysts forecast MN2 stock price to drop over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MN2 is 5.689 EUR with a low forecast of 5.633 EUR and a high forecast of 5.856 EUR.

Lowest
Price Target
5.633 EUR
65% Downside
Average
Price Target
5.689 EUR
65% Downside
Highest
Price Target
5.856 EUR
64% Downside
Mentice AB Competitors:
Price Targets
FORA
Forian Inc
95% Upside
HSTM
HealthStream Inc
21% Upside
OPRX
OPTIMIZERx Corp
53% Upside
2251
Beijing Airdoc Technology Co Ltd
31% Upside
IUG
Intelligent Ultrasound Group PLC
131% Upside
DH
Definitive Healthcare Corp
99% Upside
DOCS
Doximity Inc
30% Upside
2413
M3 Inc
53% Upside

Revenue
Forecast

Revenue Estimate
Mentice AB

For the last 5 years the compound annual growth rate for Mentice AB's revenue is 12%. The projected CAGR for the next 3 years is 23%.

12%
Past Growth
23%
Estimated Growth
Estimates Accuracy
-6%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Mentice AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
70%
Average Beat

Net Income
Forecast

Net Income Estimate
Mentice AB

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is MN2's stock price target?
Price Target
5.689 EUR

According to Wall Street analysts, the average 1-year price target for MN2 is 5.689 EUR with a low forecast of 5.633 EUR and a high forecast of 5.856 EUR.

What is Mentice AB's Revenue forecast?
Projected CAGR
23%

For the last 5 years the compound annual growth rate for Mentice AB's revenue is 12%. The projected CAGR for the next 3 years is 23%.